Explore
Cancer Immunology
0 Ungluers have
Faved this Work
Login to Fave
The past decade has seen immunotherapy rise to the forefront of cancer treatment. This Special Issue of Cancers aims to elaborate on the latest developments, cutting-edge technologies, and prospects in cancer immunology and immunotherapy. Seventeen exceptional studies, including original contributions and review articles, written by international scientists and physicians, primarily concerning the fields of tumor biology, cancer immunology, therapeutics, and drug development, comprise the main body of this Special Issue.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 45 times via unglue.it ebook links.
- 45 - pdf (CC BY) at Unglue.it.
Keywords
- Adaptive Immunity
- anti-CD20 antibody
- anti-CTLA-4
- anti-PD-1
- antibody-dependent cellular cytotoxicity (ADCC)
- Antigen Presenting Cells
- antigen-presenting cells
- Atypical Chemokine Receptor 4 (ACKR4)
- B cell aplasia
- BAP1
- BiFab
- bispecific antibody
- Cancer
- cancer stem cells (CSCs)
- cancer vaccine
- CAR T
- carcinoma
- CD19-CAR-T
- CD28
- cell therapy
- chemo-enzymatic approach
- chemotherapy
- classical and endemic Kaposi Sarcoma
- colon cancer
- colorectal cancer
- combination immunotherapy
- CTLA-4
- Cytotoxicity
- Dendritic Cells
- differentiation
- DNA Methylation
- epidemiologic studies
- Fab
- IDO inhibitor
- IFN-γ
- IL-7
- IL15
- immune checkpoint blockade
- immune checkpoint inhibitors
- immune checkpoints
- Immune Evasion
- Immunomodulation
- Immunosuppression
- Immunotherapy
- indoleamine 2,3 dioxygenase 1
- inhibitory CAR
- innate immunity
- interferon
- KIR
- kynurenine pathway
- m6A
- medicine
- Melanoma
- MICA/B mAb
- multi-state modelling
- n/a
- NK cells
- NKG2D
- Organ Transplantation
- osteoclasts
- PD-1
- PD-L1
- primary liver cancer
- prostate cancer
- Resistance
- RNA methylation
- S-adenosylmethionine (SAM)
- sortase A
- systemic treatment
- T cells
- T-cell priming
- TCR diversity
- TIL
- treatment free interval
- Treg cells
- triple negative breast cancer
- tryptophan 2,3 dioxygenase 2
- Tumor microenvironment
- Tumor-infiltrating lymphocytes
- uveal
Links
DOI: 10.3390/books978-3-0365-2572-3Editions